Deputy CEO Gareth Friedlander Discusses Discovery Life’s Claims Benefits

Published: June 20, 2022, 6:02 a.m.

Gareth Friedlander is the Deputy CEO at Discovery Life - a position he has held since January 2020. He joined the Discovery ecosystem in 2008 and has since held various positions at the company. Friedlander started this journey as an Actuarial Analyst, before becoming the Head of Life Technical Marketing in 2010, and then taking up the role of Head of Research and Development at Discovery Life in 2013. In this What’s Next interview, Aki Anastasiou meets with Friedlander to discuss Discovery Life’s various claims benefits. Friedlander begins by explaining the innovative Discovery Life proactive claims feature and the benefits this offers to clients. He also talks about the latest technology trends Discovery Life is seeing in the insurance industry and explains how the company is leveraging this insight to enhance the customer experiences it provides. He then goes into more detail on several award-winning world-first innovations from Discovery that are designed to make it easier for advisors and clients to sign up for policies. Friedlander also highlights Discovery Life’s Cancer Exome Sequencing cover and other benefits targeted at cancer patients. He then talks about the general Discovery Life claims experience, including how it is designed with clients in mind, and concludes by explaining what goes into developing this experience.